Results of a phase 1, single ascending dose, placebo-controlled study of abbv-8e12 in patients with progressive supranuclear palsy and phase 2 study design in early alzheimer’s disease

Alzheimers & Dementia(2017)

引用 8|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要